CSL Aktie

 

With more than 600k average monthly users on the HotCopper forums, each…...

CSL will launch clinical trials of its new Horizon 2 plasma process in 2027, seeking enhanced yields and regulatory approvals. The post CSL launches clinical trials for new plasma manufacturing process appeared first on The Motley Fool Australia....

Here's what I expect from the beaten-down biotech stock next month. The post Should I buy CSL shares before the end of July? appeared first on The Motley Fool Australia....

Will CSL surprise or disappoint investors? The post What to expect from CSL shares this reporting season appeared first on The Motley Fool Australia....

CSL plans to begin submitting regulatory filings for expanded pediatric indication for ANDEMBRY in the first half of the company's fiscal year Full data to be presented at upcoming scientific congress KING OF PRUSSIA, Pa., July 27, 2026 /PRNewswire/ -- Global biotechnology leader CSL......

Broker targets suggest the worst may already be priced into CSL shares. The post A $75 billion collapse: Can CSL shares stage a comeback? appeared first on The Motley Fool Australia....

After a tough year, the prognosis is looking up, this broker says. The post How high does UBS think CSL shares will go? appeared first on The Motley Fool Australia....

Find insight on Roche Holding, CSL, and Ipsen in the latest Market Talks covering Health Care....

Is there any sign of a turnaround coming? The post Down 55% in a year: Do brokers still rate CSL shares as a buy? appeared first on The Motley Fool Australia....

Find insight on CSL, Sandoz Group and more in the latest Market Talks covering the Health Care sector....

One offers steadier income, while the other could offer more upside if confidence returns. The post CSL vs Telstra shares, which should I buy? appeared first on The Motley Fool Australia....

Experts remain divided despite CSL's sharp rebound from multi-year lows. The post Could CSL shares double from here? Here's what the experts think appeared first on The Motley Fool Australia....

The market is focused on the problems, but I think the decade-long opportunity still looks attractive. The post Here's why I'd buy and hold CSL and Cochlear shares for 10 years appeared first on The Motley Fool Australia....

Can CSL shares keep climbing higher? The post Here's what brokers tip for CSL shares over the next 12 months appeared first on The Motley Fool Australia....

Was it a good idea to buy the biotech giant's shares in 2016? Here are the returns. The post How have CSL shares performed over 10 years? appeared first on The Motley Fool Australia....

Would the Sage from Omaha be interested in Australia's fallen giant? The post Would Warren Buffett buy CSL shares? appeared first on The Motley Fool Australia....

CSL Group übernimmt IoTM Solutions zur Stärkung der globalen eSIM-Orchestrierung...

Adding proven SIM management scale and 100+ operator access to accelerate SGP.32 eSIM readiness LONDON, July 13, 2026 /PRNewswire/ -- CSL Group, the leading global provider of Critical Connectivity®, has acquired IoTM Solutions Ltd, creating a global platform for resilient, multi-carrier......

Can CSL shares continue their comeback? The post CSL shares are up 35% since early June. Is the recovery here to stay? appeared first on The Motley Fool Australia....

Brokers see long-term value despite differing views on near-term upside. The post Where could CSL shares go next? Here's what brokers are predicting appeared first on The Motley Fool Australia....